![](/img/cover-not-exists.png)
443 Notch3-targeted antibody drug conjugates have superior preclinical efficacy to Notch signaling inhibitors
Geles, K.G., Gao, Y., Sridharan, L., Giannakou, A., Yamin, T.T., Golas, J., Charati, M., Lucas, J., Wang, K., Pirie-Shepherd, S., Roy, M., Follettie, M., Maderna, A., Li, X., Tchistiakova, L., Gerber,Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70569-6
Date:
November, 2014
File:
PDF, 61 KB
english, 2014